With iPSCs continuing to emerge as an important source of starting materials for cell therapy developers, it is crucial to ...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...
This article is based on a poster originally authored by Malika Bsibsi, A. Popalzij, Matteo Zanella, Lieke Geerts, Mark Musters, Inês Ferreira, Stefan Kostense, David F. Fischer and Marijn Vlaming, ...
Shares of Century Therapeutics, Inc. (IPSC) have gained 9.7% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term ...
About Century Therapeutics Century Therapeutics (NASDAQ: IPSC) is a clinical-stage biotechnology company advancing a pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback